Ryan Haumschild, PharmD, MS, MBA from Pharmacy Times - Journalist Profile

	Profile	Recent Articles on Subject
1	Kirollos Hanna, PharmD, BCPS, BCOP Pharmacy Times	Improving Transitions of Care for Patients Receiving Bispecific Therapies and Final Recommendations - about 1 month ago Administering Bispecifics in the Community vs Academic Centers - about 1 month ago Resources and Education for Operationalizing Bispecifics - about 2 months ago Dosing Frequency and Formulary Decisions for Bispecific Antibodies - 2 months ago Best Practices for Standardizing Step-Up Dosing - 2 months ago Operationalizing Bispecific Therapy and the Impact of CAR-T Advancements on Sequencing - 2 months ago Current Landscape of Bispecific Therapies for RRMM - 2 months ago
2	Gabe Hinojosa, PharmD, BCOP Pharmacy Times	Improving Transitions of Care for Patients Receiving Bispecific Therapies and Final Recommendations - about 1 month ago Administering Bispecifics in the Community vs Academic Centers - about 1 month ago Resources and Education for Operationalizing Bispecifics - about 2 months ago Dosing Frequency and Formulary Decisions for Bispecific Antibodies - 2 months ago Best Practices for Standardizing Step-Up Dosing - 2 months ago Operationalizing Bispecific Therapy and the Impact of CAR-T Advancements on Sequencing - 2 months ago Current Landscape of Bispecific Therapies for RRMM - 2 months ago
3	Brooke Peters, PharmD, BCOP Pharmacy Times	Improving Transitions of Care for Patients Receiving Bispecific Therapies and Final Recommendations - about 1 month ago Administering Bispecifics in the Community vs Academic Centers - about 1 month ago Resources and Education for Operationalizing Bispecifics - about 2 months ago Dosing Frequency and Formulary Decisions for Bispecific Antibodies - 2 months ago Best Practices for Standardizing Step-Up Dosing - 2 months ago Operationalizing Bispecific Therapy and the Impact of CAR-T Advancements on Sequencing - 2 months ago Current Landscape of Bispecific Therapies for RRMM - 2 months ago
4	Issam S. Hamadeh, PharmD, BCPS, BCOP Pharmacy Times	Improving Transitions of Care for Patients Receiving Bispecific Therapies and Final Recommendations - about 1 month ago Administering Bispecifics in the Community vs Academic Centers - about 1 month ago Resources and Education for Operationalizing Bispecifics - about 2 months ago Dosing Frequency and Formulary Decisions for Bispecific Antibodies - 2 months ago Best Practices for Standardizing Step-Up Dosing - 2 months ago Operationalizing Bispecific Therapy and the Impact of CAR-T Advancements on Sequencing - 2 months ago Current Landscape of Bispecific Therapies for RRMM - 2 months ago
5	Ryan Haumschild, PharmD, MS, MBA Pharmacy Times Director of Pharmacy. Editorial Board member. Atlanta, Georgia pharmacyhealthcareeditorial workadvisory	Improving Transitions of Care for Patients Receiving Bispecific Therapies and Final Recommendations - about 1 month ago Administering Bispecifics in the Community vs Academic Centers - about 1 month ago Resources and Education for Operationalizing Bispecifics - about 2 months ago Dosing Frequency and Formulary Decisions for Bispecific Antibodies - 2 months ago Best Practices for Standardizing Step-Up Dosing - 2 months ago Operationalizing Bispecific Therapy and the Impact of CAR-T Advancements on Sequencing - 2 months ago Current Landscape of Bispecific Therapies for RRMM - 2 months ago Bridging the Gap: Multidisciplinary Collaboration in Early Breast Cancer Care - 8 months ago Navigating Therapy Approval for Early Breast Cancer: An Operational Perspective - 8 months ago Alternative Treatments for eBC and mBC - 8 months ago Balancing Clinical and Economic Factors in Early Breast Cancer Treatment - 8 months ago Team Approach to Meeting REMS Program Requirements - 8 months ago Considerations for Maintenance Therapy in the Community Oncology Setting - 8 months ago Key Points of Emphasis Surrounding CDK4/6 Inhibitor in mBC Treatment - about 1 year ago Unmet Needs in mBC Treatment Landscape - about 1 year ago Navigating Medication Therapy Management in mBC Treatment - about 1 year ago NCCN Guidelines on CDK4/6 Inhibitor Treatment Regimens - over 1 year ago Differentiating Between Adverse Event Profiles of Various CDK4/6 Inhibitors - over 1 year ago Progression-Free Survival and Overall Survival Associated With CDK4/6 Inhibitor Therapy - over 1 year ago Hormone Therapy in Patients with HR+/HER2- Metastatic Breast Cancer - over 1 year ago Experts Discuss Oncology Drug Shortages, Patient Access in Oncology - over 1 year ago
6	Britny Brown, PharmD, BCOP Pharmacy Times	Bridging the Gap: Multidisciplinary Collaboration in Early Breast Cancer Care - 8 months ago Navigating Therapy Approval for Early Breast Cancer: An Operational Perspective - 8 months ago Alternative Treatments for eBC and mBC - 8 months ago Balancing Clinical and Economic Factors in Early Breast Cancer Treatment - 8 months ago
7	Heather Moore, BCOP, CPP, PharmD Pharmacy Times	Bridging the Gap: Multidisciplinary Collaboration in Early Breast Cancer Care - 8 months ago Navigating Therapy Approval for Early Breast Cancer: An Operational Perspective - 8 months ago Alternative Treatments for eBC and mBC - 8 months ago Balancing Clinical and Economic Factors in Early Breast Cancer Treatment - 8 months ago
8	Frank Scimeca, PharmD, MBA, BCOP Pharmacy Times	Bridging the Gap: Multidisciplinary Collaboration in Early Breast Cancer Care - 8 months ago Navigating Therapy Approval for Early Breast Cancer: An Operational Perspective - 8 months ago Alternative Treatments for eBC and mBC - 8 months ago Balancing Clinical and Economic Factors in Early Breast Cancer Treatment - 8 months ago
9	Ke Ning, MD Pharmacy Times	Team Approach to Meeting REMS Program Requirements - 8 months ago Considerations for Maintenance Therapy in the Community Oncology Setting - 8 months ago
10	Sarah Rockwell, PharmD, BCOP Pharmacy Times	Team Approach to Meeting REMS Program Requirements - 8 months ago Considerations for Maintenance Therapy in the Community Oncology Setting - 8 months ago